BHVN logo

Biohaven Pharmaceutical Holding (BHVN) Operating Expenses

Annual Operating Expenses

$436.05 M
-$131.88 M-23.22%

31 December 2023

BHVN Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Expenses

$178.17 M
-$155.60 M-46.62%

30 September 2024

BHVN Quarterly Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BHVN Operating Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-23.2%+61.2%
3 y3 years+280.8%+250.2%
5 y5 years+94.2%+32.0%

BHVN Operating Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-23.2%+280.8%-46.6%+250.2%
5 y5 years-23.2%+280.8%-46.6%+250.2%
alltimeall time-23.2%+4397.2%-46.6%+5872.8%

Biohaven Pharmaceutical Holding Operating Expenses History

DateAnnualQuarterly
Sept 2024
-
$178.17 M(-46.6%)
June 2024
-
$333.77 M(+82.2%)
Mar 2024
-
$183.24 M(+19.2%)
Dec 2023
$436.05 M(-23.2%)
$153.71 M(+39.0%)
Sept 2023
-
$110.55 M(+17.6%)
June 2023
-
$94.01 M(+20.9%)
Mar 2023
-
$77.78 M(-63.6%)
Dec 2022
$567.93 M(+159.4%)
$213.41 M(+215.5%)
Sept 2022
-
$67.64 M(-65.7%)
June 2022
-
$197.11 M(+119.6%)
Mar 2022
-
$89.77 M(+76.4%)
Dec 2021
$218.90 M(+91.2%)
-
Dec 2021
-
$50.88 M(-8.3%)
Sept 2021
-
$55.49 M(-71.7%)
Dec 2020
$114.51 M(-76.1%)
-
Dec 2020
-
$195.85 M(+10.9%)
Sept 2020
-
$176.58 M(+5.6%)
June 2020
-
$167.23 M(+10.3%)
Mar 2020
-
$151.67 M(+12.3%)
Dec 2019
$479.12 M
-
DateAnnualQuarterly
Dec 2019
-
$135.00 M(+49.3%)
Sept 2019
-
$90.45 M(-54.6%)
June 2019
-
$199.21 M(+265.8%)
Mar 2019
-
$54.46 M(+13.3%)
Dec 2018
$224.55 M(+108.7%)
-
Dec 2018
-
$48.07 M(-12.5%)
Sept 2018
-
$54.94 M(+44.1%)
June 2018
-
$38.12 M(-54.3%)
Mar 2018
-
$83.44 M(+194.8%)
Dec 2017
$107.58 M(+77.4%)
-
Dec 2017
-
$28.30 M(-28.5%)
Sept 2017
-
$39.57 M(+56.9%)
June 2017
-
$25.22 M(+74.0%)
Mar 2017
-
$14.50 M(-36.5%)
Dec 2016
$60.64 M(+525.4%)
-
Dec 2016
-
$22.84 M(-18.3%)
Sept 2016
-
$27.96 M(+308.5%)
June 2016
-
$6.85 M(+129.5%)
Mar 2016
-
$2.98 M
Dec 2015
$9.70 M
-

FAQ

  • What is Biohaven Pharmaceutical Holding annual total operating expenses?
  • What is the all time high annual operating expenses for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding annual operating expenses year-on-year change?
  • What is Biohaven Pharmaceutical Holding quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding quarterly operating expenses year-on-year change?

What is Biohaven Pharmaceutical Holding annual total operating expenses?

The current annual operating expenses of BHVN is $436.05 M

What is the all time high annual operating expenses for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high annual total operating expenses is $567.93 M

What is Biohaven Pharmaceutical Holding annual operating expenses year-on-year change?

Over the past year, BHVN annual total operating expenses has changed by -$131.88 M (-23.22%)

What is Biohaven Pharmaceutical Holding quarterly total operating expenses?

The current quarterly operating expenses of BHVN is $178.17 M

What is the all time high quarterly operating expenses for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high quarterly total operating expenses is $333.77 M

What is Biohaven Pharmaceutical Holding quarterly operating expenses year-on-year change?

Over the past year, BHVN quarterly total operating expenses has changed by +$67.62 M (+61.17%)